Clinical trial Recruiting at 1 site Interventional Ages 18 to 85

Understanding muscle recovery after inactivity

Official title: Muscle Immune Cells During Disuse and Recovery in Aging and Metabolic Disease

Run by University of Utah · NCT04416191 · Data updated 2026-11-12

This study is testing how well muscles recover after being inactive for two weeks in healthy people aged 18-35 and 60-85.

Quick facts

Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment45 (estimated)
SponsorUniversity of Utah
Academic / other
Locations1 site (Salt Lake City, Utah)
StatusRecruiting
StartedMay 15, 2022
Main results expectedApril 30, 2027
Study endsApril 30, 2028
Registry record updatedDecember 5, 2025
Trial IDNCT04416191 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are healthy individuals aged 18-35 or 60-85 who can provide informed consent.

Probably not a fit

Patients with a history of cardiovascular, endocrine, metabolic, or vascular diseases, as well as those on anticoagulant therapy, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study aims to enroll healthy individuals aged 18-35 and 60-85 to investigate how muscle health recovers following a period of inactivity. Participants will undergo a series of tests, including blood screenings, biopsies, and muscle strength assessments, before and after a 2-week leg immobilization period. The study will track changes in muscle health and immune cell activity during this recovery phase over the course of 1-2 months.

Why it matters

Potential benefit: If successful, this study could provide insights into improving muscle recovery strategies for individuals experiencing disuse.

How similar studies have gone: While there have been studies on muscle disuse and recovery, this specific approach focusing on immune cells during disuse is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age between 18-35 and 60-85 yrs
2. Ability to sign informed consent
3. Free-living, prior to admission

Exclusion Criteria:

* History of cardiovascular disease (e.g., CHF, CAD, right-to-left shunt)
* History of endocrine or metabolic disease such as hypo/hyperthyroidism and diabetes
* History of kidney disease or failure
* Vascular disease
* Risk of DVT including family history of thrombophilia, DVT, pulmonary emboli, myeloproliferative diseases including polycythemia (Hb\>18 g/dL) or thrombocytosis (platelets\>400x103/mL), and connective tissue diseases (positive lupus anticoagulant), hyperhomocystinemia, deficiencies of factor V Leiden, proteins S and C, and antithrombine III
* Use of anticoagulant therapy (e.g., Coumadin, heparin)
* Elevated systolic pressure \>150 or a diastolic blood pressure \> 100
* Implanted electronic devices (e.g., pacemakers, electronic infusion pumps, stimulators)
* Cancer or history of successfully treated cancer (less than 1 year) other than basal cell carcinoma
* Currently on a weight-loss diet
* Chronic systemic corticosteroid use (≥ 2 weeks) within 4 weeks of enrollment and for study duration (intra-articular/topical/inhaled therapeutic or physiologic doses of corticosteroids are permitted)
* Androgens or growth hormone within 6 months of enrollment and for study duration (topical physiologic androgen replacement is permitted)
* History of stroke with motor disability
* A recent history (\<12 months) of GI bleed
* History of liver disease
* History of respiratory disease (acute upper respiratory infection, history of chronic lung disease)
* Pregnancy as determined by a pregnancy test
* Any staff members who report directly to an investigator or who report to someone who reports directly to an investigator.
* Any other condition or event considered exclusionary by the PI and faculty physician

Where it's running

  • The University of Utah
    Salt Lake City, Utah, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.